Regulation of macrophage differentiation and polarization by group IVC phospholipase A 2

Biochemical and Biophysical Research Communications

Volumn 416, Issue 3-4, 2011, Pages 325-330

  Ishihara, Keiichi ^a   Kuroda, Asuka ^a   Sugihara, Kanako ^a   Kanai, Shiho ^a   Nabe, Takeshi ^a   Akiba, Satoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Group IVC phospholipase A 2; Inflammation; Lysophosphatidylcholine; Macrophage differentiation; Macrophage polarization

Indexed keywords

LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPID; SHORT HAIRPIN RNA;

ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL POLARITY; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HYDROLYSIS; MACROPHAGE; POLARIZATION; PRIORITY JOURNAL;

CELL ADHESION; CELL DIFFERENTIATION; CELL POLARITY; CELLS, CULTURED; FATTY ACIDS, NONESTERIFIED; GENE KNOCKDOWN TECHNIQUES; GROUP IV PHOSPHOLIPASES A2; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LYSOPHOSPHATIDYLCHOLINES; MACROPHAGES; MONOCYTES; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84855906440     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.034     Document Type: Article

References (35)

1. 2+-dependent translocation domain with homology to PKC and GAP. Cell 1991, 65:1043-1051.
2. 2. J. Biol. Chem. 1997, 272:16709-16712.
3. 2. J. Lipid Mediat. Cell Signal 1995, 12:83-117.
4. 2 to the nuclear envelope and endoplasmic reticulum. J. Biol. Chem. 1995, 270:30749-30754.
5. Tucker D.E., Ghosh M., Ghomashchi F., Loper R., Suram S., John B.S., Girotti M., Bollinger J.G., Gelb M.H., Leslie C.C. Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2α in regulating interfacial kinetics and binding and cellular function. J. Biol. Chem. 2009, 284:9596-95611.
6. 2 biochemistry. Cardiovasc. Drugs Ther. 2009, 23:49-59.
7. Asai K., Hirabayashi T., Houjou T., Uozumi N., Taguchi R., Shimizu T. Human group IVC phospholipase A2 (cPLA2). Roles in the membrane remodeling and activation induced by oxidative stress. J. Biol. Chem. 2003, 278:8809-8814.
8. Tucker D.E., Stewart A., Nallan L., Bendale P., Ghomashchi F., Gelb M.H., Leslie C.C. Group IVC cytosolic phospholipase A2 is farnesylated and palmitoylated in mammalian cells. J. Lipid Res. 2005, 46:2122-2133.
9. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
10. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
11. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 2005, 352:1685-1695.
12. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
13. Osterud B., Bjorklid E. Role of monocytes in atherogenesis. Physiol. Rev. 2003, 83:1069-1112.
14. 2 suppresses production of cholesteryl ester through the reesterification of free cholesterol but not formation of foam cells in oxidized LDL-stimulated macrophages. Biol. Pharm. Bull. 2008, 31:6-12.
15. Goerdt S., Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999, 10:137-142.
16. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M. The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol. 2004, 25:677-686.
17. Gordon S., Taylor P.R. Monocyte andmacrophage heterogeneity. Nat. Rev. Immunol. 2005, 5:953-964.
18. Mosser D.M., Edwards J.P. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 2008, 8:958-969.
19. Gordon S. Alternative activation of macrophages. Nat. Rev. Immunol. 2003, 3:23-35.
20. Scotton C.J., Martinez F.O., Smelt M.J., Sironi M., Locati M., Mantovani A., Sozzani S. Transcriptional profiling reveals complex regulation of the monocyte IL-1 beta system by IL-13. J. Immunol. 2005, 174:834-845.
21. Martinez F.O., Gordon S., Locati M., Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 2006, 177:7303-7311.
22. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
23. Tjiu J.W., Chen J.S., Shun C.T., Lin S.J., Liao Y.H., Chu C.Y., Tsai T.F., Chiu H.C., Dai Y.S., Inoue H., Yang P.C., Kuo M.L., Jee S.H. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J. Invest. Dermatol. 2009, 129:1016-1025.
24. Lopez-Castejón G., Baroja-Mazo A., Pelegrín P. Novel macrophage polarization Model: from gene expression to identification of new anti-inflammatory molecules. Cell Mol. Life Sci. 2011, 68:3095-3107.
25. Underwood K.W., Song C., Kriz R.W., Chang X.J., Knopf J.L., Lin L.-L. A novel calcium-independent phospholipase A2, cPLA2-,γ that is prenylated and contains homology to cPLA2. J. Biol. Chem. 1998, 273:21926-21932.
26. 2 γ. J. Biol. Chem. 2002, 277:29526-29536.
27. Jenkins C.M., Han X., Yang J., Mancuso D.J., Sims H.F., Muslin A.J., Gross R.W. Purification of recombinant human cPLA2γ and identification of C-terminal farnesylation, proteolytic processing, and carboxymethylation by MALDI-TOF-TOF analysis. Biochemistry 2003, 42:11798-11807.
28. 2 in human monocyte-derived macrophages. Atheroscler. Thromb. Vasc. Biol. 2000, 20:1276-1282.
29. Kume N., Cybulsky M.I., Gimbrone-Jr M.A. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J. Clin. Invest. 1992, 90:1138-1144.
30. Rong J.X., Berman J.W., Taubman M.B., Fisher E.A. Lysophosphatidylcholine stimulates monocyte chemoattractant protein-1 gene expression in rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 2002, 22:1617-1623.
31. 2-like activity and lysophosphatidylcholine formation. Arterioscler. Thromb. Vasc. Biol. 2003, 23:461-467.
32. Aviram M., Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radical. Biol. Med. 2004, 37:1304-1316.
33. Rosenblat M., Vaya J., Shih D., Aviram M. Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine. Atherosclerosis 2005, 179:69-77.
34. Shalhoub J., Falck-Hansen M.A., Davies A.H., Monaco C. Innate immunity and monocyte-macrophage activation in atherosclerosis. J. Inflammation 2011, 8:9.
35. Khallou-Laschet J., Varthaman A., Fornasa G., Compain C., Gaston A.T., Clement M., Dussiot M., Levillain O., Graff-Dubois S., Nicoletti A., Caligiuri G. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010, 5:e8852.